LABOMAR
MID SMALL CAP FORUM-EUROPE
Madrid, November 3rd, 2022
TODAY SPEAKERS
WALTER BERTIN | CLAUDIO DE NADAI |
Founder & CEO | IR & Board Director |
CLAUDIO CRESPAN
CFO
FRANCESCO DA RIVA
Head of Sales
Founded Labomar in 1998 from the "Farmacia Bertin"
Member of Assindustria Veneto Centro since 2012
Graduated in pharmaceutical science and completed a Master degree in Lean Mangement
Consultant for Labomar since 2007 on financial strategy and Board Member since 2018, he led the asset deal of ImportFab and Welcare
After 13 yars as CFO and General Manager of an Italian SME and a past entrepreneurial experience in agri-food, he founded BModel (corporate finance boutique)
Joined Labomar Group in 2021 and appointed as CFO
15 years in extensive previous experience as CFO and M&A in international structured Companies, previous experience in a big4 Audit Firm.
Vice President of ANDAF North East (CFO association)
Significant experience in Labomar, first as Head of Foreign Sales and since the beginning of 2020 as Head of Sales and Commercial Networks
Extensive previous experience as Senior Consultant in Strategy and Business Planning
Education: MiMAC 1 (SDA Bocconi School of Management) EMBA 16 (CUOA Business School)
2
AGENDA
1
2
3
Heritage,
Vision & Mission,
Sustainability
Labomar
Stand Alone
Labomar Business Model Evolution
4 | 1H 2022 Results, |
3Q 2022 Revenues | |
and 2022 Guidance | |
5 | Focus Single |
Controlled Companies |
3
AGENDA
1
2
3
Heritage,
Vision & Mission,
Sustainability
Labomar
Stand Alone
Labomar Business
Model Evolution
4 | 1H 2022 Results, |
3Q 2022 Revenues | |
and 2022 Guidance |
5 | Focus Single |
Controlled Companies |
4
HERITAGE
Foundation of | |||
LABOMAR RESEARCH, | |||
the R&D Branch | |||
of Labomar; | Fondo Italiano | ||
the company | |||
starts building | Labomar starts | d'Investimento invests | Since 2016 |
its reserach-driven | in Labomar's equity | ||
building a | Start of the Lean | ||
DNA | |||
committed qualified | Transformation | ||
management team | process |
1998 | 2004 | 2011 | 2015 | 2018 |
November, acquisition of Importfab, Canada-basedPharma
CMO
Equity investment (5%) in Project Zero srl, devolping vertical farming techniques for vegetal extracts
Establishment of Herbae srl (now Labomar Next srl)
2020
2021
July
Acquisition of the majority of Welcare Research srl, Italian company specialized in wound healing medical devices
September
Set up of Labovar srl, a commercial company that will sell online
in the Chinese market
Acquisition of the 17,6% of Labiotre srl. With this partecipation, Labomar owns 48,8% of Labiotre srl.
November
Labomar owns 100% of Labiotre srl
2003 2008
Labomar begins its transformation from pharmaceutical lab to industrial manufacturing company
Foundation of LABOMAR from the pharmacy of Dr. Bertin
2012 2016
Foundation of Labiotre | |
s.r.l., to guarantee the | |
highest possible quality | |
of raw materials | Roll-off of the |
Attainment of the | brand-new, |
GMP and ISO9001 | pharmagrade |
certifications | standard L3 plant |
2019
Juanuary
Dr Bertin buys back minorities and owns 100% of Labomar
August
Statue Change
October
Listing on Milan stock exchange
December
Labomar exercises call option andacquires an additional 7%
of Welcare Research srl, increasing its stake to 70%
COMING SOON
L6 new headquarter and production plant construction
Source: Management
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Labomar S.p.A. published this content on 28 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 November 2022 09:59:08 UTC.